1. As Bev notes - DEA claims pharmacist should have seen a patient’s naloxone Rx as a red flag. Naloxone is the standard of care for most patients who receive and use opioids. In many, many states, it is now mandated to be co-prescribed with opioids.
Mar 23, 2022 • 5 tweets • 1 min read
I work in KY as an SUD provider. Generally I have very few issues with Kratom - anecdotally for a few of my patients, it seemed to generate tolerance really quickly, so it got very expensive very fast, but I haven’t seen data to support. 1/5
The bigger issue some of my patients have had is that they don’t always know that they’re using it - it has a bunch of different names and is even in some workout supplements, etc. I’ve had a couple of people referred to me for naltrexone “allergies” when they 2/5
Mar 17, 2022 • 10 tweets • 2 min read
I think a lot about the time that a former colleague said to me about patient care (this was with respect to urine drug screens) - “trust is a two-way street.” Which, like many platitudes, has a nugget of truth. But, to me, it’s a huge part of what is wrong in SUD treatment. 1/
Because here’s the deal: I absolutely have to earn my patients’ trust. They have to trust that I have the training, background, and ongoing interest in updating my knowledge base to help them reach *their* goals. 2/
Sep 24, 2021 • 9 tweets • 2 min read
🚮 tweet alert! Let’s talk why. #TwitteRx#MedTwitter
Pharmacists are highly trained HCPs who are the subject matter experts in medications and treatment. *However* because of really effective MD lobbying, many of us are unable to practice independently, particularly re: decision making on therapeutics 2/